PMA device
Safire TX Ablation Catheter
Irvine Biomedical,Inc.(Ibi) · Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD, Class III) · First FDA decision Aug 21, 2007, newest Dec 16, 2022Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Safire TX"
MAUDE reports
17
Brand "Safire TX", since 2015
PubMed studies
0
Mentioning "Safire TX"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Safire TX Ablation Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Safire TX Ablation Catheter, Therapy Dual-8 Ablation Catheter, Safire TX, Catheter Extension CablePMA supplement
P040042-S053 · Decided Dec 16, 2022 · 49 days after receipt · Normal 180 Day Track No User Fee
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
- Safire TX Ablation Catheter, Therapy Dual-8 Ablation Catheter, Safire TX, Catheter Extension CablePMA supplement
P040042-S052 · Decided Nov 15, 2022 · 27 days after receipt · Normal 180 Day Track No User Fee
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
- SAFIRE TX CARDIAC ABLATION CATHETER AND INTERFACE CABLESPMA supplement
P040042-S009 · Decided Aug 21, 2007 · 162 days after receipt · Normal 180 Day Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Safire TX", any status and sponsor, newest update first.
No registered device study names "Safire TX".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Safire TX", and for the whole product code for context.
This brand
17 reports: 8 malfunction, 9 injury, 0 death
Whole product code OAD
3,979 reports: 1,924 malfunction, 1,908 injury, 137 death
Newest reports for this brand
2030404-2025-00024 · Received Jun 27, 2025 · Event dated Jun 23, 2025
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Communication or Transmission Problem; Material Twisted/Bent
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2030404-2024-00052 · Received Aug 21, 2024 · Event dated Aug 14, 2024
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Cardiac Perforation
2030404-2024-00015 · Received Mar 11, 2024 · Event dated Feb 19, 2024
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Communication or Transmission Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0593-2010 · Started Nov 25, 2009 · Posted by FDA Jan 11, 2010
Reason given: This action is being taken because the product has the potential for the polyimide tubing to detach from the inner core due to the bond failure. If this occurs, treatment may be delayed or interrupted. The firm's initial health hazard analysis indicated the event may cause temporary or medically reversible adverse...
Cause as FDA categorized it: Process design · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Z-0594-2010 · Started Nov 25, 2009 · Posted by FDA Jan 11, 2010
Reason given: This action is being taken because the product has the potential for the polyimide tubing to detach from the inner core due to the bond failure. If this occurs, treatment may be delayed or interrupted. The firm's initial health hazard analysis indicated the event may cause temporary or medically reversible adverse...
Cause as FDA categorized it: Process design · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Z-0309-2007 · Started Nov 8, 2006 · Posted by FDA Dec 27, 2006
Reason given: Recall was initiated after a clinical incident involving separation of the front sheath, preventing deployment of the stent graft. This required the physician to convert the patient to conventional open repair.
Cause as FDA categorized it: Other · Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Safire TX"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OAD.
- Blazer Open-Irrigated Ablation CatheterBoston Scientific Corp · PMA 2025
- Blazer II XP Cardiac Ablation Catheter and CableBoston Scientific · PMA 2025
- FlexAbility Ablation Catheter, Sensor EnabledAbbott Medical · PMA 2025
- Therapy Dual 8 Catheter,therapy 8MM Thermistor Ablation CatheterIrvine Biomedical,Inc.(Ibi) · PMA 2016
- THERMOCOOL SMARTTOUCH® SF CatheterBiosense Webster, Inc. · PMA 2026
- Therapy Cool Path DuoAbbott Medical · PMA 2020
- VISITAG SURPOINT External Processing Unit (EPU)Biosense Webster, Inc. · PMA 2026
- Therapy Cool PathIrvine Biomedical, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.